CLINICAL ROLE -
Sarilumab Receives FDA Approval for Rheumatoid Arthritis
Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.
Read More
FDA Approves Kevzara for Rheumatoid Arthritis
Sarilumab is a human monoclonal antibody designed to bind to the interleukin-6 receptor.
Severe Asthma Drug Shows Promise
Benralizumab led to a significant reduction in the use of oral corticosteroids for patients with severe, uncontrolled eosinophilic asthma.
Antiretroviral Treatment Postpartum Improves Health in HIV-Positive Mothers
Continuing ART post-delivery shows benefits in women with early stage HIV,
5 Reasons Pre-Med Students Might Change to Pre-Pharmacy
Many pharmacy students started off as pre-meds, here are 5 reasons they may have switched.
C difficile Spikes in Travelers Returning from International Destinations
Clostridium difficile (C. difficile) infections could be a cause of travel-associated diarrhea.
Smart Trap Could Lower Spread of Zika, West Nile Mosquitoes
Traps help entomologists track mosquitoes that are carrying Zika or other harmful diseases.
Need a Leader for Your Organization? Hire a Pharmacy Manager!
Businesses need great leaders. An often unconsidered source for leadership talent are successful pharmacy managers!
Smart Trap Increasingly Accurate in Catching Zika, West Nile Mosquitoes
Houston Public Media today reported on a “smart trap” by Microsoft that Harris County Mosquito Control has been testing since summer 2016.
Vitamin D and Renal Failure: How Much Is Too Much?
As we age our bodies become less efficient at making vitamin D.
European Center for Disease Prevention and Control Provides Update on HIV
The continuum of HIV care enables countries to monitor the success of their HIV response, from diagnosis to viral suppression.
Rheumatoid Arthritis Drug Wins FDA Approval
The FDA has approved sarilumab (Kevzara) from Sanofi and Regeneron Pharmaceuticals for the treatment of adult patients with moderately to severely active rheumatoid arthritis.
NCPA Offers House Committee Suggestions to Enhance Medicare, Increase Access to Prescription Drugs
CDC: Cryptosporidium Outbreaks Linked to Swimming Have Doubled
Outbreaks of a parasitic infection linked to swimming pools and water playgrounds are increasingly being reported to CDC, with twice as many outbreaks in 2016 as in 2014.
Lower Cost Topical Steroids Could Save Millions
Low-cost generic topical steroids could save Medicare $944.8 million.
Impact of Patient Satisfaction on Specialty Pharmacy
Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.
How Are Other Countries Doing in the Continuum of HIV Care?
Non-EU and EEA countries trail behind in reaching viral suppression target by 2020.
Opioid Use Similar Between Veterans, General Public
Opioid use among Afghanistan, Iraq veterans similar to general population.
Trending News Today: 3-D Technology May Restore Fertility Lost to Chemotherapy
Top news of the day from across the health care landscape.
Obesity Increases Childhood Diabetes Risk
Children with obesity may be 4 times more likely to develop type 2 diabetes.
Trending News Today: Guidelines Recommend No Fruit Juice for Kids Under 1
Top news of the day from across the healthcare landscape.
MS Drug Class May Increase Adverse Events
Side effects associated with interferon beta for multiple sclerosis highlight the need for additional post-market surveillance for approved drugs.
Immunotherapy May Treat Multiple Cancer Types
Nanoparticle vaccines can travel directly to the lymph nodes to activate tumor-specific immune responses.
Cancer Drug Shows Promise Treating Asthma
Imatinib found to reduce measures of airway inflammation in severe asthma.
Gleevec Reduces Airway Inflammation in Severe Asthma
Cancer drug shows promise improving asthma symptoms.
Bring Your Own Weather: How Your Attitude Affects Others
How much do your actions affect those around you? Read here to learn about how to consciously change your environment.
New Cancer Drug Approvals Highlight AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
T Cell Therapy Trial Death in Top Cancer News of the Week
Top news of the week in oncology and cancer drug development.
Cognitive Issues Associated with Immune Responses to HIV, Flu
In a study published in Nature Medicine, investigators found that when a virus enters the bloodstream it activates the first responder immune cells, CX3CR1highLY6Clow monocytes.
Real-World Data Reveals Potential Adverse Events for Multiple Sclerosis Drug
Interferon beta may increase the risk of stroke, migraine, and depression among patients with multiple sclerosis.
